NO20006604L - Fremgangsmåter og transdermale sammensetninger for lindring av smerte - Google Patents
Fremgangsmåter og transdermale sammensetninger for lindring av smerteInfo
- Publication number
- NO20006604L NO20006604L NO20006604A NO20006604A NO20006604L NO 20006604 L NO20006604 L NO 20006604L NO 20006604 A NO20006604 A NO 20006604A NO 20006604 A NO20006604 A NO 20006604A NO 20006604 L NO20006604 L NO 20006604L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- pain relief
- transdermal compositions
- compositions
- amine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Det er beskrevet fremgangsmåter og sammensetninger for transdermal administrering. Det er beskrevet trekk omfattende fremgangsmåter og sammensetninger for transdermal administrering av en amininneholdende forbindelse med bifasisk oppløselighet og/eller et middel som forsterker aktiviteten av den amininneholdende forbindelsen som har bifasisk oppløselighet, for eksempel et muskelavslappende middel, for å lindre smerte.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/106,684 US6290986B1 (en) | 1996-10-24 | 1998-06-29 | Method and composition for transdermal administration of pharmacologic agents |
US12290399P | 1999-03-05 | 1999-03-05 | |
PCT/US1999/014653 WO2000000120A1 (en) | 1998-06-29 | 1999-06-29 | Methods and transdermal compositions for pain relief |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20006604D0 NO20006604D0 (no) | 2000-12-22 |
NO20006604L true NO20006604L (no) | 2001-02-28 |
Family
ID=26803907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20006604A NO20006604L (no) | 1998-06-29 | 2000-12-22 | Fremgangsmåter og transdermale sammensetninger for lindring av smerte |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP1093348A4 (no) |
JP (1) | JP2002519310A (no) |
KR (1) | KR20010078754A (no) |
CN (1) | CN1331576A (no) |
AU (1) | AU4841599A (no) |
BG (1) | BG105175A (no) |
BR (1) | BR9912508A (no) |
CA (1) | CA2335837A1 (no) |
HR (1) | HRP20000905A2 (no) |
HU (1) | HUP0102728A3 (no) |
ID (1) | ID28213A (no) |
IL (1) | IL140420A0 (no) |
MX (1) | MXPA00012767A (no) |
NO (1) | NO20006604L (no) |
PL (1) | PL345216A1 (no) |
SK (1) | SK20012000A3 (no) |
TR (1) | TR200003801T2 (no) |
WO (1) | WO2000000120A1 (no) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6572880B2 (en) * | 1996-10-24 | 2003-06-03 | Pharmaceutical Applications Associates Llc | Methods and transdermal compositions for pain relief |
CA2287255A1 (en) | 1997-04-22 | 1998-10-29 | Cocensys, Inc. | Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof |
CN1660109A (zh) | 1999-07-01 | 2005-08-31 | 法玛西雅厄普约翰美国公司 | 高度选择性去甲肾上腺素再摄取抑制剂及其用途 |
DK1493442T3 (da) * | 1999-07-01 | 2005-12-19 | Pharmacia & Upjohn Co Llc | Reboxetin til behandling af perifer neuropati |
AU1261501A (en) * | 1999-12-06 | 2001-06-18 | Stanley L. Gore | Compositions and methods for intranasal delivery of active agents to the brain |
IN191512B (no) * | 2000-01-21 | 2003-12-06 | Panacea Biotech | |
DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
DE10042412B4 (de) * | 2000-08-30 | 2005-12-22 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Abgabe von Venlafaxin, und seine Verwendung |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
PT2218448E (pt) | 2002-12-13 | 2016-01-26 | Durect Corp | Sistema oral de entrega de fármaco que compreende materiais transportadores líquidos de alta viscosidade |
JP2005154368A (ja) * | 2003-11-27 | 2005-06-16 | Teikoku Seiyaku Co Ltd | ジソピラミド含有神経因性疼痛の鎮痛剤 |
JP4807721B2 (ja) * | 2004-01-29 | 2011-11-02 | 株式会社 メドレックス | 消炎鎮痛外用剤 |
SI2415484T1 (sl) | 2004-09-17 | 2014-10-30 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
JP2007308403A (ja) * | 2006-05-17 | 2007-11-29 | Kenji Yoshida | 皮膚外用剤 |
KR100880748B1 (ko) * | 2006-08-29 | 2009-02-02 | 정헌택 | 디메톡시커큐민을 함유하는 혈관재협착 방지용 조성물 |
PT2117521E (pt) | 2006-11-03 | 2012-09-10 | Durect Corp | Sistemas de administração transdérmica que compreendem bupivacaína |
US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
EP3326621A1 (en) | 2007-12-06 | 2018-05-30 | Durect Corporation | Oral pharmaceutical dosage forms |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
US20120053134A1 (en) * | 2009-05-07 | 2012-03-01 | Jae-Hoon Jung | Pharmaceutical composition for preventing or treating neuronal damage and neurological diseases |
US8491927B2 (en) * | 2009-12-02 | 2013-07-23 | Nimble Epitech, Llc | Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor |
US9555113B2 (en) | 2013-03-15 | 2017-01-31 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
WO2015123272A1 (en) * | 2014-02-11 | 2015-08-20 | Dr. Reddy's Laboratories Ltd. | Parenteral compositions of celecoxib |
EP3870150A1 (en) | 2018-10-26 | 2021-09-01 | Viramal Limited | Mucoadhesive gel composition |
EP3659583B1 (en) | 2018-11-30 | 2023-06-07 | Viramal Limited | A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent |
CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
FR3108841B1 (fr) * | 2020-04-06 | 2023-11-03 | Algotherapeutix | Composition pharmaceutique topique sous forme de gel aqueux comprenant au moins de l’amitriptyline |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4395420A (en) * | 1981-12-09 | 1983-07-26 | Bernstein Joel E | Method and composition for treating pruritis |
SI9300468A (en) * | 1992-10-14 | 1994-06-30 | Hoffmann La Roche | Injectable composition for the sustained release of biologically active compounds |
GB9315856D0 (en) * | 1993-07-30 | 1993-09-15 | Wellcome Found | Stabilized pharmaceutical |
US5654337A (en) * | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
US5837289A (en) * | 1996-07-23 | 1998-11-17 | Grasela; John C. | Transdermal delivery of medications using a combination of penetration enhancers |
US5885597A (en) * | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
-
1999
- 1999-06-29 AU AU48415/99A patent/AU4841599A/en not_active Abandoned
- 1999-06-29 EP EP99932017A patent/EP1093348A4/en not_active Withdrawn
- 1999-06-29 CN CN99810055A patent/CN1331576A/zh active Pending
- 1999-06-29 KR KR1020007014985A patent/KR20010078754A/ko not_active Application Discontinuation
- 1999-06-29 JP JP2000556706A patent/JP2002519310A/ja active Pending
- 1999-06-29 HU HU0102728A patent/HUP0102728A3/hu unknown
- 1999-06-29 MX MXPA00012767A patent/MXPA00012767A/es unknown
- 1999-06-29 WO PCT/US1999/014653 patent/WO2000000120A1/en not_active Application Discontinuation
- 1999-06-29 SK SK2001-2000A patent/SK20012000A3/sk unknown
- 1999-06-29 ID IDW20010231A patent/ID28213A/id unknown
- 1999-06-29 TR TR2000/03801T patent/TR200003801T2/xx unknown
- 1999-06-29 IL IL14042099A patent/IL140420A0/xx unknown
- 1999-06-29 PL PL99345216A patent/PL345216A1/xx unknown
- 1999-06-29 BR BR9912508-0A patent/BR9912508A/pt not_active Application Discontinuation
- 1999-06-29 CA CA002335837A patent/CA2335837A1/en not_active Abandoned
-
2000
- 2000-12-22 NO NO20006604A patent/NO20006604L/no not_active Application Discontinuation
- 2000-12-28 HR HR20000905A patent/HRP20000905A2/hr not_active Application Discontinuation
-
2001
- 2001-01-24 BG BG105175A patent/BG105175A/bg unknown
Also Published As
Publication number | Publication date |
---|---|
JP2002519310A (ja) | 2002-07-02 |
WO2000000120A9 (en) | 2000-03-30 |
HRP20000905A2 (en) | 2001-08-31 |
MXPA00012767A (es) | 2002-08-09 |
SK20012000A3 (sk) | 2001-08-06 |
IL140420A0 (en) | 2002-02-10 |
BR9912508A (pt) | 2001-05-02 |
TR200003801T2 (tr) | 2001-06-21 |
HUP0102728A3 (en) | 2002-12-28 |
PL345216A1 (en) | 2001-12-03 |
KR20010078754A (ko) | 2001-08-21 |
NO20006604D0 (no) | 2000-12-22 |
ID28213A (id) | 2001-05-10 |
CN1331576A (zh) | 2002-01-16 |
AU4841599A (en) | 2000-01-17 |
WO2000000120A1 (en) | 2000-01-06 |
EP1093348A4 (en) | 2003-07-16 |
CA2335837A1 (en) | 2000-01-06 |
HUP0102728A2 (hu) | 2002-03-28 |
EP1093348A1 (en) | 2001-04-25 |
BG105175A (bg) | 2001-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20006604L (no) | Fremgangsmåter og transdermale sammensetninger for lindring av smerte | |
AU2003268144A1 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
WO2002053187A3 (en) | Methods and transdermal compositions for pain relief | |
ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
DK1476141T3 (da) | Manipulationssikrede anordninger til transdermal opioidadministration | |
BR0212078A (pt) | Método de tratar ou prevenir uma doença relacionada com amilóide em um paciente, composição farmacêutica, composto quìmico, e, uso de um composto | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
NO20045240L (no) | Transepikutan administrasjonsform for a behandle restless legs syndromet | |
DE60322102D1 (de) | Transdermales buprenorphin-dosierschema zwecks schmerzstillung | |
BR0213100A (pt) | Combinações para o tratamento de distúrbios imuniinflamatórios | |
NO20024646D0 (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
EA200001010A1 (ru) | Применение дексмедетомидина для седативного воздействия в отделении интенсивной терапии | |
NO20000446D0 (no) | Anvendelse av fysiologisk akseptable vanadiumforbindelser, salter og komplekser | |
SE9601528D0 (sv) | Transdermally administered dextromethorphan as antitissue agent | |
ATE536178T1 (de) | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis | |
EA200601249A1 (ru) | Пиперазины, пригодные для лечения боли | |
WO2004007676A3 (en) | Combination therapy for the treatment of neoplasms | |
WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
TR200102512T2 (tr) | Tüm ruhsal bozukluklar, adaptasyon bozuklukları ve çeşitli kaygı-depresyon bozukluklarının tedavisinde ya da önlenmesinde yararlı tıbbi ürünlerin hazırlanması için saredutan ve onun farmasötik olarak kabul edilebilir tuzlarının kullanımı. | |
TR200103418T2 (tr) | Melatoninin tedavi edici kullanımı. | |
ES2036560T3 (es) | Un metodo para preparar una composicion sinergicamente activa para el tratamiento de hipertension. | |
EA200400348A1 (ru) | Цисплатиновые составы пониженной токсичности и способы их применения | |
DK0669826T3 (da) | (-)-Metrifonatholdigt lægemiddel | |
PT1059845E (pt) | Composicao fungicida compreendendo uma benzoilfenilureia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |